Pfizer and Astellas have received the US Food and Drug Administration (FDA) acceptance for priority review of their ...

In this video, Ursula A. Matulonis, MD, discusses results from the RAMP-201 trial of combination avutometinib and defactinib in patients with recurrent low-grade serous ovarian cancer with KRAS ...

Fosfomycin-based combination therapy demonstrates favourable efficacy and tolerability in high-risk paediatric patients with ...

A new clinical practice guideline from the American Academy of Sleep Medicine provides evidence‑based recommendations on the ...

Six of eight patients (75%) with HER2-positive rectal adenocarcinoma responded to trastuzumab and tucatinib plus chemotherapy ...

Investigational treatment improves outcomes without complete complement blockade ...

A combination of brexpiprazole (Rexulti) and sertraline improved post-traumatic stress disorder (PTSD) symptoms more than sertraline alone, a phase III trial found. The primary endpoint was the change ...

FDA grants Priority Review for Padcev plus Keytruda in muscle-invasive bladder cancer, showing improved survival and reduced ...

CLEVELAND, Ohio — The benefits of getting regular exercise, combining two cancer drugs with chemotherapy, and using AI to ...

Adagene Inc. (NASDAQ:ADAG) is one of the unstoppable stocks that could double your money. On April 2, Adagene announced a ...

GLP-1RA and SGLT2 inhibitor combination therapy was associated with better cardiorenal outcomes than monotherapy among patients with type 2 diabetes. The cardiorenal benefits of sodium-glucose ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...